Ken Fisher Viridian Therapeutics, Inc.\De Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Fisher Asset Management, LLC holds 395,497 shares of VRDN stock, worth $9.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
395,497
Previous 389,087
1.65%
Holding current value
$9.03 Million
Previous $6.81 Million
24.47%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRDN
# of Institutions
152Shares Held
61.9MCall Options Held
133KPut Options Held
207K-
Black Rock Inc. New York, NY4.77MShares$109 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.92MShares$89.6 Million1.68% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$88.7 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$76.4 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.31MShares$75.6 Million0.85% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $911M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...